Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS 2023-01-12 17:00
iNtRON is finalizing the SAL200 Tech Transfer 2023-01-12 09:34
Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future 2023-01-11 08:01
Dizal Announces China CDE Acceptance of New Drug Application for Sunvozertinib for Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations 2023-01-10 17:03
FAPON to attend 41st Annual J.P. Morgan Healthcare Conference 2023-01-10 16:37
SK Inc. hosts "SK Bio Night" in San Francisco to expand global partnerships 2023-01-10 07:00
SK Biopharmaceuticals to Present Future Plan for Global Investors, Partners at 'SK Bio Night' 2023-01-10 07:00
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy 2023-01-09 23:25
SK bioscience's Zoster Vaccine Receives Biologics License Application Approval in Malaysia 2023-01-09 21:00
Immorna Receives IND Clearance to Conduct a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine 2023-01-09 20:00
Jacobio Completes First Patient Dosage of Aurora A Inhibitor JAB-2485 in U.S 2023-01-08 14:17
Fosun Pharma and Henlius Entered into an Exclusive License Agreement for Serplulimab in the US 2023-01-07 17:29
Ocedurenone (KBP-5074) Featured at ASN Kidney Week: Ocedurenone is a Potential New Treatment Option for Patients with Uncontrolled or Resistant Hypertension and Advanced CKD 2023-01-06 21:00
Double-blind period completes! Primary endpoint analysis of phase 3 clinical trial to be conducted for China's first hormone replacement treatment targeting hypoparathyroidism 2023-01-06 18:00
SK Biopharmaceuticals CEO Donghoon Lee Buys 3,000 Shares of Company Stock 2023-01-06 09:10
Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo 2023-01-05 09:00
Ascentage Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference 2023-01-05 09:00
Innovent to Present at 41st Annual J.P. Morgan Healthcare Conference 2023-01-05 00:00
OnCusp Therapeutics Announces Appointment of Robert Forrester and Chau Khuong to Board of Directors 2023-01-04 21:00
Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum 2023-01-03 23:25
1 63 64 65 66 67 222